BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 19204493)

  • 1. Applications of Capstone depleted uranium aerosol risk data to military combat risk management.
    Daxon EG; Parkhurst MA; Melanson MA; Roszell LE
    Health Phys; 2009 Mar; 96(3):380-92. PubMed ID: 19204493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological risk assessment of Capstone depleted uranium aerosols.
    Hahn FF; Roszell LE; Daxon EG; Guilmette RA; Parkhurst MA
    Health Phys; 2009 Mar; 96(3):352-62. PubMed ID: 19204491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conclusions of the Capstone depleted uranium aerosol characterization and risk assessment study.
    Parkhurst MA; Guilmette RA
    Health Phys; 2009 Mar; 96(3):393-409. PubMed ID: 19204494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation and ingestion intakes with associated dose estimates for level II and level III personnel using Capstone study data.
    Szrom F; Falo GA; Lodde GM; Parkhurst MA; Daxon EG
    Health Phys; 2009 Mar; 96(3):363-79. PubMed ID: 19204492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capstone depleted uranium aerosol biokinetics, concentrations, and doses.
    Guilmette RA; Miller G; Parkhurst MA
    Health Phys; 2009 Mar; 96(3):328-42. PubMed ID: 19204489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculating Capstone depleted uranium aerosol concentrations from beta activity measurements.
    Szrom F; Falo GA; Parkhurst MA; Whicker JJ; Alberth DP
    Health Phys; 2009 Mar; 96(3):238-50. PubMed ID: 19204483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the renal toxicity of Capstone depleted uranium oxides and other uranium compounds.
    Roszell LE; Hahn FF; Lee RB; Parkhurst MA
    Health Phys; 2009 Mar; 96(3):343-51. PubMed ID: 19204490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the Capstone depleted uranium study of aerosols from impact with armored vehicles: test setup and aerosol generation, characterization, and application in assessing dose and risk.
    Parkhurst MA; Guilmette RA
    Health Phys; 2009 Mar; 96(3):207-20. PubMed ID: 19204481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of Capstone depleted uranium aerosols I: uranium concentration in aerosols as a function of time and particle size.
    Parkhurst MA; Cheng YS; Kenoyer JL; Traub RJ
    Health Phys; 2009 Mar; 96(3):251-65. PubMed ID: 19204484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol sampling system for collection of Capstone depleted uranium particles in a high-energy environment.
    Holmes TD; Guilmette RA; Cheng YS; Parkhurst MA; Hoover MD
    Health Phys; 2009 Mar; 96(3):221-37. PubMed ID: 19204482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of Capstone depleted uranium aerosols III: morphologic and chemical oxide analyses.
    Krupka KM; Parkhurst MA; Gold K; Arey BW; Jenson ED; Guilmette RA
    Health Phys; 2009 Mar; 96(3):276-91. PubMed ID: 19204486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods used to calculate doses resulting from inhalation of Capstone depleted uranium aerosols.
    Miller G; Cheng YS; Traub RJ; Little TT; Guilmette RA
    Health Phys; 2009 Mar; 96(3):306-27. PubMed ID: 19204488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of Capstone depleted uranium aerosols IV: in vitro solubility analysis.
    Guilmette RA; Cheng YS
    Health Phys; 2009 Mar; 96(3):292-305. PubMed ID: 19204487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization of Capstone depleted uranium aerosols II: particle size distributions as a function of time.
    Cheng YS; Kenoyer JL; Guilmette RA; Parkhurst MA
    Health Phys; 2009 Mar; 96(3):266-75. PubMed ID: 19204485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose assessment for inhalation intakes in complex, energetic environments: experience from the US Capstone study.
    Guilmette RA; Parkhurst MA
    Radiat Prot Dosimetry; 2007; 127(1-4):516-20. PubMed ID: 17766261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gulf war depleted uranium risks.
    Marshall AC
    J Expo Sci Environ Epidemiol; 2008 Jan; 18(1):95-108. PubMed ID: 17299528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on the Capstone Depleted Uranium (DU) Aerosol Characterization and Risk Assessment Study.
    Lykken GI; Momcilović B
    Health Phys; 2010 Jan; 98(1):77; author reply 77-8. PubMed ID: 19959955
    [No Abstract]   [Full Text] [Related]  

  • 18. Measuring aerosols generated inside armoured vehicles perforated by depleted uranium ammunition.
    Parkhurst MA
    Radiat Prot Dosimetry; 2003; 105(1-4):167-70. PubMed ID: 14526950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risks of out of area missions: depleted uranium].
    Ciprani F; Moroni M
    G Ital Med Lav Ergon; 2006; 28(1):115-21. PubMed ID: 16705900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental and health consequences of depleted uranium use in the 1991 Gulf War.
    Bem H; Bou-Rabee F
    Environ Int; 2004 Mar; 30(1):123-34. PubMed ID: 14664872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.